๐๏ธ Verified NIH Record โข Updated 2026-01-16
Communication Skills Intervention to Promote Transition Into Survivorship (NCT01483664)
๐ต Active, Not Recruiting Interventional Protocol ๐ Observational Clinical Research Sponsor: Memorial Sloan Kettering Cancer Center
๐ฉบ Plain-English Summary (8th-Grade Level)
The purpose of this study is to improve the communication skills of physicians who transition lymphoma cancer patients from the end of treatment to survivorship.
Who can join: Review the eligibility criteria below.
Location: Tampa General Hospital โ Tampa, Florida
Age range: 18 Years
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (9 Sites)
- Tampa General Hospital โ Tampa, Florida
- Moffitt Cancer Center โ Tampa, Florida
- Memorial Sloan Kettering at Basking Ridge โ Basking Ridge, New Jersey
- Maimonides Medical Center โ Brooklyn, New York
- Memorial Sloan Kettering Cancer Center at Commack โ Commack, New York
- Memorial Sloan Kettering Cancer Center โ New York, New York
- Memorial Sloan Kettering Cancer Center at Mercy โ Rockville Centre, New York
- Memorial Sloan Kettering Cancer Center at Phelps โ Sleepy Hollow, New York
- Md Anderson Cancer Center โ Houston, Texas
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Hodgkin's Lymphoma
- EBV CTLs Expressing CD30 Chimeric Receptors For CD 30+ Lymphoma โ Houston, Texas
- A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma โ Houston, Texas
- CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30) โ Houston, Texas
Explore by condition: All Hodgkin's Lymphoma clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.